+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neurological Drug"

Rare Neurological Disease Treatment Global Market Report 2024 - Product Thumbnail Image

Rare Neurological Disease Treatment Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Modified Release Neurology Therapeutics - Product Thumbnail Image

Modified Release Neurology Therapeutics

  • Report
  • January 2024
  • 125 Pages
  • Global
From
From
Muscarinic Acetylcholine Receptor Global Market Report 2024 - Product Thumbnail Image

Muscarinic Acetylcholine Receptor Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
5-HT1 Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

5-HT1 Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
Global Tardive Dyskinesia Treatment Market 2024-2028 - Product Thumbnail Image

Global Tardive Dyskinesia Treatment Market 2024-2028

  • Report
  • November 2023
  • 147 Pages
  • Global
From
From
From
Global Neurologic Disorders Therapeutics Market 2022-2026 - Product Thumbnail Image

Global Neurologic Disorders Therapeutics Market 2022-2026

  • Report
  • May 2022
  • 120 Pages
  • Global
From
From
Cerebral Palsy - Pipeline Review, H2 2020 - Product Thumbnail Image

Cerebral Palsy - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 50 Pages
  • Global
From
From
Stem Cell Therapies in Neurology - Product Thumbnail Image

Stem Cell Therapies in Neurology

  • Report
  • September 2018
  • 67 Pages
  • Global
From
Loading Indicator

The Neurological Drug market is composed of drugs used to treat diseases and disorders of the Central Nervous System (CNS). These drugs are used to treat a wide range of conditions, including Alzheimer's disease, Parkinson's disease, epilepsy, multiple sclerosis, and stroke. CNS drugs are also used to treat psychiatric disorders, such as depression, anxiety, and schizophrenia. These drugs are typically administered orally, intravenously, or intramuscularly. The Neurological Drug market is highly competitive, with many large pharmaceutical companies competing for market share. Companies such as Pfizer, Merck, Novartis, and GlaxoSmithKline are some of the major players in the market. Other companies, such as Eli Lilly, AstraZeneca, and Sanofi, also have a presence in the market. Additionally, there are many smaller companies that specialize in the development and manufacture of CNS drugs. Show Less Read more